SNCA and Parkinson disease: In this study, we investigated the anti-Parkinson’s effect of DOP using the C. elegans transgenic strain NL5901, which expresses human α-synuclein fused to the yellow fluorescent protein (YFP) in body-wall muscle cells [45,46,47].